Evaluation of Rapid Onset of Action of ICS/LABA Combination Therapies on Respiratory Function in Asthma Patients: A Single-Center, Open-Label, Randomized, Crossover Trial

INTRODUCTION: Products based on inhaled corticosteroid (ICS)/long-acting β2 agonist (LABA) combinations may provide different clinical benefits. This study was conducted to compare the rapid effects of three such combination products: formoterol/fluticasone (FFC) aerosol (pMDI), formoterol/budesonid...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohbayashi, Hiroyuki, Kudo, Sahori, Ariga, Mitsue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967249/
https://www.ncbi.nlm.nih.gov/pubmed/32026393
http://dx.doi.org/10.1007/s41030-018-0062-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967249/
https://www.ncbi.nlm.nih.gov/pubmed/32026393
http://dx.doi.org/10.1007/s41030-018-0062-x

Ejemplares similares